Susquehanna International Group, LLP Tiziana Life Sciences LTD Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 61,530 shares of TLSA stock, worth $104,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,530
Previous 86,085
28.52%
Holding current value
$104,601
Previous $136,000
4.41%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.06MCall Options Held
32KPut Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI2.74MShares$4.65 Million4.04% of portfolio
-
Marshall Wace, LLP London, X0268KShares$455,6200.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny241KShares$409,3830.0% of portfolio
-
Morgan Stanley New York, NY97.1KShares$165,0730.0% of portfolio
-
Zhang Financial LLC84.2KShares$143,1400.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $174M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...